Lantheus Holdings Inc (FRA:0L8)

€ 88.82 3.24 (3.79%) Market Cap: 6.14 Bil Enterprise Value: 5.91 Bil PE Ratio: 15.32 PB Ratio: 5.43 GF Score: 91/100

Q3 2024 Lantheus Holdings Inc Earnings Call Transcript
Nov 06, 2024

€106.75 (+0.95%)

Earnings
Q2 2024 Lantheus Holdings Inc Earnings Call Transcript
Jul 31, 2024

€102.25 (-0.10%)

Earnings
Q1 2024 Lantheus Holdings Inc Earnings Call Transcript
May 02, 2024

€62.4 (+0.06%)

Earnings
Q4 2023 Lantheus Holdings Inc Earnings Call Transcript
Feb 22, 2024

€60.08 (+14.96%)

Earnings
Lantheus Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Lantheus Holdings Inc Earnings Call Transcript
Nov 02, 2023

€62.4 (+2.46%)

Earnings
Q2 2023 Lantheus Holdings Inc Earnings Call Transcript
Aug 03, 2023

€65.58 (-13.19%)

Earnings
Lantheus Holdings Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Q1 2023 Lantheus Holdings Inc Earnings Call Transcript
May 04, 2023

€79.48 (+5.86%)

Earnings
Q4 2022 Lantheus Holdings Inc Earnings Call Transcript
Feb 23, 2023

€65 (+19.27%)

Earnings
Lantheus Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Lantheus Holdings Inc Earnings Call Transcript
Nov 03, 2022

€67 (-8.84%)

Earnings
Q2 2022 Lantheus Holdings Inc Earnings Call Transcript
Aug 04, 2022

€70.5 (-6.00%)

Earnings
Lantheus Holdings Inc at UBS Global Healthcare Conference Transcript
May 24, 2022
Lantheus Holdings Inc Investor Day Transcript
May 17, 2022
Q1 2022 Lantheus Holdings Inc Earnings Call Transcript
Apr 29, 2022

€61 (+11.93%)

Earnings
Lantheus Holdings Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Q4 2021 Lantheus Holdings Inc Earnings Call Transcript
Feb 24, 2022

€25.2 (-1.56%)

Earnings
Lantheus Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Q3 2021 Lantheus Holdings Inc Earnings Call Transcript
Nov 04, 2021

€21.2 (+1.92%)

Earnings
Q2 2021 Lantheus Holdings Inc Earnings Call Transcript
Jul 28, 2021

€21.2 (-0.93%)

Earnings
Q1 2021 Lantheus Holdings Inc Earnings Call Transcript
May 04, 2021

€19.6 (-0.51%)

Earnings
Q4 2020 Lantheus Holdings Inc Earnings Call Transcript
Feb 25, 2021

€16.1 (+3.21%)

Earnings
Lantheus Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2020
Q3 2020 Lantheus Holdings Inc Earnings Call Transcript
Nov 05, 2020

€9.55 (+0.53%)

Earnings
Q2 2020 Lantheus Holdings Inc Earnings Call Transcript
Jul 30, 2020

€13.3 (+3.10%)

Earnings
Lantheus Holdings Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 19, 2020
Q1 2020 Lantheus Holdings Inc Earnings Call Transcript
Apr 30, 2020

€12.8 (+7.56%)

Earnings
Q4 2019 Lantheus Holdings Inc Earnings Call Transcript
Feb 25, 2020

€14.8 (-3.27%)

Earnings
Lantheus Holdings Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019
Q3 2019 Lantheus Holdings Inc Earnings Call Transcript
Oct 31, 2019

€17.8 (+0.56%)

Earnings
Lantheus Holdings, Inc., Progenics Pharmaceuticals, Inc. - M&A Call Transcript
Oct 02, 2019
Q2 2019 Lantheus Holdings Inc Earnings Call Transcript
Jul 25, 2019

€25.92 (+3.06%)

Earnings
Lantheus Holdings Inc at UBS Global Healthcare Conference Transcript
May 21, 2019
Q1 2019 Lantheus Holdings Inc Earnings Call Transcript
Apr 30, 2019

€22.37 (-0.49%)

Earnings
Q4 2018 Lantheus Holdings Inc Earnings Call Transcript
Feb 20, 2019

€17.2 (+5.20%)

Earnings

Q3 2024 Lantheus Holdings Inc Earnings Call Transcript

Nov 06, 2024 / 01:00PM GMT

Release Date Price: €106.75 (+0.95%)

Transcript 10-Q8-K

Operator

Good morning. Welcome to the Lantheus third-quarter 2024 conference call. (Operator Instructions) This call is being recorded, and a replay would be available in the Investors section of the company's website approximately two hours after the completion of the call and will be archived for at least 30 days.

I'll now turn the call over to Mark Kinarney, Vice President of Investor Relations. Mark?

Mark Kinarney

Lantheus Holdings Inc - Vice President, Investor Relations

Thank you. Good morning.

With me today are Brian Markison, our CEO; Paul Blanchfield, our President; Bob Marshall, our CFO; Jeff Humphrey, our Chief Medical Officer; and Amanda Morgan, our Chief Commercial Officer. We will begin with prepared remarks and then open the call for Q&A.

This morning, we issued a press release which was furnished to the SEC under Form 8-K, reporting our third-quarter 2024 results. The release and today's slide presentation are in the Investors section of our website.

Any comments made could include forward-looking statements.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.